Sponsor Pipeline

Edward Wood, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 4
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07118670 High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes Proliferative Diabetic Retinopathy (PDR) Active, Not Recruiting
Get alerts when Edward Wood, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free